India vs Korea: Proportion of isolates with decreased susceptibility or resistance
India
0
in 2020
Korea
0
in 2018
India rank
13th
Korea rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- India
- Korea
How they compare
India currently reports 0 against 0 in Korea, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2009 it was Korea ahead.
India ranks 13th and Korea ranks 13th of 52 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.81 | 29.27 | 18.46 | Korea |
| 2010s | 4.11 | 15.66 | 11.55 | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, India or Korea?
- India, at 0 against 0 in Korea as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between India and Korea?
- 0, with India ahead.
- How many years of comparable data are there for India and Korea?
- 9 years are reported by both, from 2009 to 2018.
- How do India and Korea rank globally for proportion of isolates with decreased susceptibility or resistance?
- India ranks 13th and Korea ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.